dihexa pnb-0408 c-met hgfr activator Buy – CAS 1401708-83-5 Drug development of MET inhibitors:
Drug development of MET inhibitors: targeting oncogene addiction and expedience Nature Reviews Drug Discovery dihexa peptide cognitive enhancement neurodegeneration Growth Factors and Their Application in the Therapy of Hereditary Neurodegenerative Diseases Dihexa (PNB 0408) c Met HGFR Activator dihexa dementia Dihexa (PNB 0408) c Met HGFR Activator dihexa chemical properties solubility stability Cabozantinib hydrochloride c Met inhibitor CAS 1817759 42 4 Pancreatic Cancer Treatment Targeting the HGF c MET Pathway: The MEK Inhibitor Trametinib
Pay in 4 interest-free payments of $6.73 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7




